New hope for ALS: trial tests drug to slow devastating disease
Disease control
Not yet recruiting
This study is testing a new drug called PLL001 for people recently diagnosed with ALS (Lou Gehrig's disease). The main goal is to see if daily injections can safely slow down the loss of physical function and improve survival. About 153 participants will receive either the real d…
Phase: PHASE1, PHASE2 • Sponsor: PLL TX AUSTRALIA PTY LTD • Aim: Disease control
Last updated Apr 02, 2026 07:41 UTC